Review
Open access
Sep 2026
Therapeutic vaccines for NSCLC: From mechanisms to clinical translation
Despite advances in targeted therapy and immune checkpoint inhibitors (ICIs), durable disease control remains elusive for most patients with non-small cell lung cancer (NSCLC), particularly those with advanced-stage disease. Therapeutic cancer vaccines offer the potential for sustained immune surveillance by inducing t...
Wei-Jing Liu, Jie-Fei Han, Kai-Lun Fei et al.
· Chinese Medical Journal - Pu... · 0 citations